相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
David Jayne et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
Eric F. Morand et al.
LANCET RHEUMATOLOGY (2022)
The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease
Faye A. H. Cooles et al.
LANCET RHEUMATOLOGY (2022)
Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation
Allison C. Billi et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Belimumab for systemic lupus erythematosus - Focus on lupus nephritis
Marlene Pluess et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
Which is the best SLE activity index for clinical trials?
Koichiro Ohmura
MODERN RHEUMATOLOGY (2021)
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Dennis S. W. Lee et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment
Francois Chasset et al.
FRONTIERS IN PHARMACOLOGY (2021)
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
Ian N. Bruce et al.
LANCET RHEUMATOLOGY (2021)
A Successful Trial for Lupus - How Good Is Good Enough?
Jane E. Salmon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1) a randomised, controlled, phase 3 trial
Richard A. Furie et al.
LANCET RHEUMATOLOGY (2019)
Interferon pathway in SLE: one key to unlocking the mystery of the disease
Lars Ronnblom et al.
LUPUS SCIENCE & MEDICINE (2019)
Type I interferon in rheumatic diseases
Theresa L. Wampler Muskardin et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity
William D. Shipman et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
Jeffrey M. Riggs et al.
LUPUS SCIENCE & MEDICINE (2018)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE)
Kenneth C. Kalunian et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
New insights into the immunopathogenesis of systemic lupus erythematosus
George C. Tsokos et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Systemic lupus erythematosus
Arvind Kaul et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Dose-escalation of human anti-interferon-alpha receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study
Avram Goldberg et al.
ARTHRITIS RESEARCH & THERAPY (2014)
The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score
I. Braunstein et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus
Rachel Klein et al.
ARCHIVES OF DERMATOLOGY (2011)
Interferon Alpha as a Primary Pathogenic Factor in Human Lupus
Timothy B. Niewold
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Structural characterization of a human Fc fragment engineered for lack of effector functions
Vaheh Oganesyan et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)